Published in Int J Nanomedicine on March 18, 2015
Nanotechnology-based drug delivery systems for the treatment of Alzheimer's disease. Int J Nanomedicine (2015) 0.81
Superparamagnetic reconstituted high-density lipoprotein nanocarriers for magnetically guided drug delivery. Int J Nanomedicine (2017) 0.79
Topical ophthalmic lipid nanoparticle formulations (SLN, NLC) of indomethacin for delivery to the posterior segment ocular tissues. Eur J Pharm Biopharm (2016) 0.78
A new bifunctional hybrid nanostructure as an active platform for photothermal therapy and MR imaging. Sci Rep (2016) 0.77
Enhanced detection with spectral imaging fluorescence microscopy reveals tissue- and cell-type-specific compartmentalization of surface-modified polystyrene nanoparticles. J Nanobiotechnology (2016) 0.75
Enhanced in Vitro Anti-Tumor Activity of 5-Azacytidine by Entrapment into Solid Lipid Nanoparticles. Adv Pharm Bull (2016) 0.75
Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells. Nano Lett (2006) 10.12
Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. Int J Pharm (2005) 7.53
The effect of particle design on cellular internalization pathways. Proc Natl Acad Sci U S A (2008) 7.06
Nanoparticles in cancer therapy and diagnosis. Adv Drug Deliv Rev (2002) 7.05
Shape effects of filaments versus spherical particles in flow and drug delivery. Nat Nanotechnol (2007) 6.85
Role of target geometry in phagocytosis. Proc Natl Acad Sci U S A (2006) 6.62
Immunological properties of engineered nanomaterials. Nat Nanotechnol (2007) 5.59
Local actin polymerization and dynamin recruitment in SV40-induced internalization of caveolae. Science (2002) 5.41
Nanoparticle and targeted systems for cancer therapy. Adv Drug Deliv Rev (2004) 5.31
Biodegradable polymeric nanoparticles based drug delivery systems. Colloids Surf B Biointerfaces (2009) 4.06
Interacting phospholipid bilayers: measured forces and induced structural changes. Annu Rev Biophys Bioeng (1981) 3.63
Live dynamic imaging of caveolae pumping targeted antibody rapidly and specifically across endothelium in the lung. Nat Biotechnol (2007) 3.54
Properties of the glomerular barrier and mechanisms of proteinuria. Physiol Rev (2008) 3.49
Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues. Adv Drug Deliv Rev (2008) 3.41
In vivo diffusion analysis with quantum dots and dextrans predicts the width of brain extracellular space. Proc Natl Acad Sci U S A (2006) 3.37
Population context determines cell-to-cell variability in endocytosis and virus infection. Nature (2009) 3.37
Endocytosis of nanomedicines. J Control Release (2010) 3.23
Size and shape effects in the biodistribution of intravascularly injected particles. J Control Release (2009) 3.08
Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy. Adv Drug Deliv Rev (2009) 3.08
Multifunctional gold nanoparticle-peptide complexes for nuclear targeting. J Am Chem Soc (2003) 2.83
Endocytosis in filter-grown Madin-Darby canine kidney cells. J Cell Biol (1989) 2.65
Nanocarriers' entry into the cell: relevance to drug delivery. Cell Mol Life Sci (2009) 2.63
Auto-catalytic ceria nanoparticles offer neuroprotection to adult rat spinal cord neurons. Biomaterials (2007) 2.62
Vascular events after spinal cord injury: contribution to secondary pathogenesis. Phys Ther (2000) 2.61
Defining macropinocytosis. Traffic (2009) 2.56
Recent approaches to intracellular delivery of drugs and DNA and organelle targeting. Annu Rev Biomed Eng (2006) 2.39
Endocytic mechanisms for targeted drug delivery. Adv Drug Deliv Rev (2007) 2.38
A reexamination of active and passive tumor targeting by using rod-shaped gold nanocrystals and covalently conjugated peptide ligands. ACS Nano (2010) 2.27
Systematic surface engineering of magnetic nanoworms for in vivo tumor targeting. Small (2009) 2.16
Transepithelial transport of immunoglobulins. Annu Rev Immunol (1994) 2.10
Cell penetrating peptides: intracellular pathways and pharmaceutical perspectives. Pharm Res (2007) 2.08
Mechanisms of quantum dot nanoparticle cellular uptake. Toxicol Sci (2009) 2.08
Nanoparticles as potential oral delivery systems of proteins and vaccines: a mechanistic approach. J Control Release (2006) 2.05
Frontiers in cancer nanomedicine: directing mass transport through biological barriers. Trends Biotechnol (2010) 1.90
Clathrin-dependent endocytosis. Biochem J (2004) 1.89
Nanoparticles: a boon to drug delivery, therapeutics, diagnostics and imaging. Nanomedicine (2011) 1.87
Scavenger receptors mediate cellular uptake of polyvalent oligonucleotide-functionalized gold nanoparticles. Bioconjug Chem (2010) 1.85
Making polymeric micro- and nanoparticles of complex shapes. Proc Natl Acad Sci U S A (2007) 1.84
Endocytosis unplugged: multiple ways to enter the cell. Cell Res (2010) 1.74
Targeting cancer cells using PLGA nanoparticles surface modified with monoclonal antibody. J Control Release (2007) 1.73
Brownian motion of an ellipsoid. Science (2006) 1.68
Penetration of intact skin by quantum dots with diverse physicochemical properties. Toxicol Sci (2006) 1.65
Receptor-mediated transcytosis: a mechanism for active extravascular transport of nanoparticles in solid tumors. J Control Release (2012) 1.61
Efficacy of transferrin-conjugated paclitaxel-loaded nanoparticles in a murine model of prostate cancer. Int J Cancer (2004) 1.60
Surface charge of nanoparticles determines their endocytic and transcytotic pathway in polarized MDCK cells. Biomacromolecules (2008) 1.59
Ultrasound for drug and gene delivery to the brain. Adv Drug Deliv Rev (2008) 1.58
Factors controlling nanoparticle pharmacokinetics: an integrated analysis and perspective. Annu Rev Pharmacol Toxicol (2011) 1.58
Receptor-mediated endocytosis in renal proximal tubule. Pflugers Arch (2009) 1.58
Synthesis, stability, and cellular internalization of gold nanoparticles containing mixed peptide-poly(ethylene glycol) monolayers. Anal Chem (2007) 1.58
Molecular mechanisms of phagocytic uptake in mammalian cells. Cell Mol Life Sci (2008) 1.57
Size-dependent cellular uptake and expulsion of single-walled carbon nanotubes: single particle tracking and a generic uptake model for nanoparticles. ACS Nano (2009) 1.54
Solid lipid nanoparticles for enhancing vinpocetine's oral bioavailability. J Control Release (2006) 1.52
Brain delivery of camptothecin by means of solid lipid nanoparticles: formulation design, in vitro and in vivo studies. Int J Pharm (2012) 1.51
Penetration of metallic nanoparticles in human full-thickness skin. J Invest Dermatol (2007) 1.47
Computer simulation of the translocation of nanoparticles with different shapes across a lipid bilayer. Nat Nanotechnol (2010) 1.45
Effects and uptake of gold nanoparticles deposited at the air-liquid interface of a human epithelial airway model. Toxicol Appl Pharmacol (2009) 1.39
Nanoparticles for direct nose-to-brain delivery of drugs. Int J Pharm (2009) 1.36
Size and dynamics of caveolae studied using nanoparticles in living endothelial cells. ACS Nano (2009) 1.33
The journey of a drug-carrier in the body: an anatomo-physiological perspective. J Control Release (2011) 1.32
Sparfloxacin-loaded PLGA nanoparticles for sustained ocular drug delivery. Nanomedicine (2009) 1.29
Cdc42 regulates Fc gamma receptor-mediated phagocytosis through the activation and phosphorylation of Wiskott-Aldrich syndrome protein (WASP) and neural-WASP. Mol Biol Cell (2009) 1.27
Orotransmucosal drug delivery systems: a review. J Control Release (2009) 1.27
Cellular uptake and cytotoxicity of silica nanotubes. Nano Lett (2008) 1.27
Macrophages recognize size and shape of their targets. PLoS One (2010) 1.26
Preparation and evaluation of reverse-phase evaporation and multilamellar niosomes as ophthalmic carriers of acetazolamide. Int J Pharm (2005) 1.24
Microfabricated particles for engineered drug therapies: elucidation into the mechanisms of cellular internalization of PRINT particles. Pharm Res (2008) 1.23
Biodegradable nanoparticles composed entirely of safe materials that rapidly penetrate human mucus. Angew Chem Int Ed Engl (2011) 1.23
Transdermal delivery of mixnoxidil with block copolymer nanoparticles. J Control Release (2004) 1.19
Galactosylated chitosan/DNA nanoparticles prepared using water-soluble chitosan as a gene carrier. Biomaterials (2004) 1.18
Targeting receptor-mediated endocytotic pathways with nanoparticles: rationale and advances. Adv Drug Deliv Rev (2012) 1.18
Transport of nanoparticles across an in vitro model of the human intestinal follicle associated epithelium. Eur J Pharm Sci (2005) 1.16
Biocompatibility of engineered nanoparticles for drug delivery. J Control Release (2012) 1.14
Evaluating the uptake and intracellular fate of polystyrene nanoparticles by primary and hepatocyte cell lines in vitro. Toxicol Appl Pharmacol (2009) 1.09
Lipid nanocarriers improve paclitaxel transport throughout human intestinal epithelial cells by using vesicle-mediated transcytosis. J Control Release (2009) 1.07
Cancer-cell-phenotype-dependent differential intracellular trafficking of unconjugated quantum dots. Small (2009) 1.07
Chitosan-based nanostructures: a delivery platform for ocular therapeutics. Adv Drug Deliv Rev (2009) 1.06
The characteristics, cellular uptake and intracellular trafficking of nanoparticles made of hydrophobically-modified chitosan. J Control Release (2010) 1.04
Methotrexate loaded polyether-copolyester dendrimers for the treatment of gliomas: enhanced efficacy and intratumoral transport capability. Mol Pharm (2008) 1.04
Proline-rich, amphipathic cell-penetrating peptides. Adv Drug Deliv Rev (2007) 1.02
A sensitive in vivo model for quantifying interstitial convective transport of injected macromolecules and nanoparticles. J Appl Physiol (1985) (2006) 1.01
Polyplex micelles with cyclic RGD peptide ligands and disulfide cross-links directing to the enhanced transfection via controlled intracellular trafficking. Mol Pharm (2009) 1.01
Is there a clinical future for polymeric nanoparticles as brain-targeting drug delivery agents? Drug Discov Today (2011) 1.00
The use of cell-penetrating peptides for drug delivery. Drug Discov Today (2004) 1.00
Imaging of size-dependent uptake and identification of novel pathways in mouse Peyer's patches using fluorescent organosilica particles. Nanomedicine (2011) 0.99
Surface modifications of nanocarriers for effective intracellular delivery of anti-HIV drugs. Adv Drug Deliv Rev (2009) 0.99
Gateways and tools for drug delivery: endocytic pathways and the cellular dynamics of cell penetrating peptides. Int J Pharm (2007) 0.98
Bioreducible hyperbranched poly(amido amine)s for gene delivery. Biomacromolecules (2009) 0.98
Drug delivery to inflamed colon by nanoparticles: comparison of different strategies. Int J Pharm (2012) 0.97
Interfacial interactions between natural RBC membranes and synthetic polymeric nanoparticles. Nanoscale (2014) 0.97
The role of liver sinusoidal cells in hepatocyte-directed gene transfer. Am J Pathol (2009) 0.95
Biorecognition and subcellular trafficking of HPMA copolymer-anti-PSMA antibody conjugates by prostate cancer cells. Mol Pharm (2009) 0.95
Development of a quercetin-loaded nanostructured lipid carrier formulation for topical delivery. Int J Pharm (2012) 0.94
Tumor-targeting multifunctional micelles for imaging and chemotherapy of advanced bladder cancer. Nanomedicine (Lond) (2012) 0.94
Incorporation of biodegradable nanoparticles into human airway epithelium cells-in vitro study of the suitability as a vehicle for drug or gene delivery in pulmonary diseases. Biochem Biophys Res Commun (2004) 0.94
Specific renal uptake of randomly 50% N-acetylated low molecular weight chitosan. Mol Pharm (2009) 0.93
Particle shape: a new design parameter for passive targeting in splenotropic drug delivery. J Pharm Sci (2010) 0.93
Uptake mechanisms of non-viral gene delivery. J Control Release (2011) 0.93
Site of drug absorption after oral administration: assessment of membrane permeability and luminal concentration of drugs in each segment of gastrointestinal tract. Eur J Pharm Sci (2006) 0.93
Nanomedicines for overcoming biological barriers. Biomed Pharmacother (2004) 0.92
Non-functionalized multi-walled carbon nanotubes alter the paracellular permeability of human airway epithelial cells. Toxicol Lett (2008) 0.92